Xue Shui

Development and Application of a Real-time PCR Method for Pharmacokinetic and Biodistribution Studies of Recombinant Adenovirus

Xianxing Xu, Xue Shui, Zhi-hang Chen, 2009, Molecular biotechnology.

Monoamine oxidase A drives neuroendocrine differentiation in prostate cancer

Changhong Shi, Cai-qin Zhang, Jumei Zhao, 2022, Biochemical and Biophysical Research Communications.

Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin

H. Dudek, J. Tao, Dongyu Chen, 2016, Molecular Cancer Therapeutics.

Advances in neuroendocrine prostate cancer research: From model construction to molecular network analyses

Changhong Shi, Jumei Zhao, Xue Shui, 2021, Laboratory Investigation.

RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade

S. Ganesh, Weimin Wang, M. Abrams, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1

E. Salido, H. Dudek, B. Holmes, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models

H. Dudek, S. Ganesh, Weimin Wang, 2017, Molecular Cancer Therapeutics.

Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin

H. Dudek, J. Tao, Dongyu Chen, 2016, Molecular Cancer Therapeutics.